About Juliet Bakker
Juliet Bakker chairs Endogenex's board and has served since 2007 as a managing director at Longitude Capital, a healthcare venture capital firm. Endogenex is evaluating an endoscopic system intended to restore duodenal signaling and help people with type 2 diabetes control blood glucose. She also founded Longitude.
Earlier, she was a Pequot Ventures managing director, held strategy and operations roles at Waste Management International, analyzed equities at Banque Paribas, and worked in PaineWebber corporate finance. Her current boards include Bolt Medical, Ceribell, Nalu Medical, RxSight and Sydnexis. She is also a Cornell trustee, a CALS Advisory Council member and a Boys and Girls Club of Greenwich board member. Selected earlier boards include Ablation Frontiers, Alphaeon, AqueSys, Axonics Modulation Technologies, CryoVascular Systems, Eargo, Embolic Protection, Enteric Medical, eyeonics, Genyx Medical, Insulet, Precision Dermatology, Sadra Medical and Venus Concept. She holds an MPA from Harvard Kennedy School and a BSc from Cornell's College of Agriculture and Life Sciences.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Juliet Bakker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Juliet Bakker works with at each company, as listed on that company's latest Form D.
